Back
MFS Multimarket Income Trust Vs. Summit Therapeutics Industry Stock Comparison
Sell
41
MMT
MFS Multimarket Income Trust
Last Price:
4.83
Seasonality Move:
-1.82%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Sell
41
MFS Multimarket Income Trust (MMT)
is a Sell
Is MFS Multimarket Income Trust a Buy, Sell or Hold?
- The current MFS Multimarket Income Trust [MMT] share price is $4.84. The Score for MMT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- MMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MMT Stock Price Chart
What is MFS Multimarket Income Trust's stock price today?
-
The MFS Multimarket Income Trust share price today is $4.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
MMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 63.32 | Buy |
Chaikin Money Flow: | 64038 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.74 - 4.82) | Buy |
Bollinger Bands (100): | (4.61 - 4.77) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.35 | Buy |
Relative Strength Index (14 RSI): | 80.76 | Buy |
Chaikin Money Flow: | -10383890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.54 - 21.66) | Buy |
Bollinger Bands (100): | (4.24 - 14.54) | Buy |
MMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.81 | Buy |
20-day SMA: | 4.79 | Buy |
50-day SMA: | 4.75 | Buy |
200-day SMA: | 4.63 | Buy |
8-day EMA: | 4.81 | Buy |
20-day EMA: | 4.79 | Buy |
50-day EMA: | 4.75 | Buy |
200-day EMA: | 4.64 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.3 | Buy |
20-day SMA: | 16.66 | Buy |
50-day SMA: | 12.66 | Buy |
200-day SMA: | 6.49 | Buy |
8-day EMA: | 23.98 | Buy |
20-day EMA: | 18.55 | Buy |
50-day EMA: | 13.95 | Buy |
200-day EMA: | 7.85 | Buy |
MFS Multimarket Income Trust Earnings Growth & MMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
MFS Multimarket Income Trust Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |